Obinutuzumab and Chlorambucil: A Promising Duo for Anti-MAG Antibody Polyneuropathy?
Discover how obinutuzumab and chlorambucil are emerging as potential game-changers in treating anti-MAG antibody polyneuropathy. Learn about the latest research, patient outcomes, and what this could mean for future treatments.